Expanding Our Portfolio to Support the NHS | Wellbeing Software
Request a Demo
Wellbeing Software Data

Expanding Our Portfolio to Support the NHS

We have recently expanded our portfolio to include pathology and oncology software solutions to support integrated diagnostic services and help ease the burden on the NHS as a result of the pandemic.

We are now able to offer hospitals and NHS Trusts additional solutions including our enterprise Laboratory Information System EVOLUTION, and Oncology Information Management Solution CHARM®.

This expansion follows our acquisition by The Citadel Group, a leading Australian software and services company that specialises in secure enterprise information management in complex environments, including healthcare. The acquisition has enabled us to further invest in the development of its core healthcare software products, while also moving forward to offer customers these market leading solutions in pathology and oncology from a single specialist vendor.

Chris Yeowart, Director at Wellbeing Software said: “This follows months of hard work from the teams at Citadel and Wellbeing to realise the benefits of bringing together their industry leading and highly complementary solution portfolios. The launch of these additional products in the UK will help in supporting patient care and when deployed together, will promote a more joined-up way of working, especially in diagnostic services.”

Stephen Lynch, General Manager at Citadel Health said: “We are very happy to be working with Wellbeing as they bring our healthcare products to the UK market. The introduction of the EVOLUTION and CHARM® solutions is a great step forward as we can now offer comprehensive workflow management to NHS trusts across a much greater range of departments and disciplines.”

If you would like to know more or want to arrange a demo, contact us here.

Subscribe to our newsletter

To stay up to date with our latest news and events, sign up to our mailing list.


For more information please see our privacy policy.